Delivery Order SPE2DR25D9239-SPE2DR26FFBR9
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,396.58 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60 count). This firm fixed-price delivery order, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, was awarded without a set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order, issued on December 9, 2025, with an ultimate completion date of December 10, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. The award is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,729.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count). The award, issued on December 15, 2025, with an ultimate completion date of December 16, 2025, was made under firm fixed-price terms with no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 13, 2025, was not set aside for any particular business category. DMS Pharmaceutical Group will perform under this order from...
- The Defense Logistics Agency awarded a $24,729.64 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for supply of Jakafi 10 mg tablets (60-count units). The delivery order, issued on November 28, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, indicating the award was made through open competition. This delivery order is issued under DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,089.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units). The contract, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $24,493.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 15 mg tablets (60-count units). This firm fixed-price delivery order, awarded on December 2, 2025, with an ultimate completion date of December 3, 2025, was issued without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,338.41 to DMS Pharmaceutical Group Inc. for 60 tablets of Jakafi 20mg on November 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, leverages DMS Pharmaceutical Group's position as a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. The company will perform the work at its Park Ridge facility and deliver the product to support Department of...
- The Defense Logistics Agency awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). The award, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating the vendor's competitive capability in unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on November 20, 2025, with an ultimate completion date of November 21, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement....
- SPE2DR25D9239Indefinite Delivery Contract
- SPE2DR25D9239-SPE2DR26FFBR9Delivery Order
The Defense Logistics Agency (DLA) awarded a $12,378.73 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 25 mg tablets (60-count units). The award, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform under this delivery order at its Park Ridge facility, leveraging its established role as a critical pharmaceutical supplier within the Department of Defense's medical supply chain. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy designed to support recurring pharmaceutical and medical consumable needs across military healthcare facilities worldwide. The underlying IDC, valued at $499,999,999 and awarded on November 13, 2025, extends through December 31, 2036, with a 30-month base period and three optional 30-month periods. As a single-award prime vendor contractor under this framework, DMS Pharmaceutical Group is positioned to deliver diverse pharmaceutical products spanning branded and generic prescription medications, biologics, and specialty pharmaceuticals to support global Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 12/17/25 |